Efficacy and Safety of Biosimilar QL1207 vs. the Reference Aflibercept for Patients with Neovascular Age-Related Macular Degeneration: A Randomized Phase 3 Trial

被引：0

作者：

Bing Li

Ke Fan

Tonghe Zhang

Zhifeng Wu

Siming Zeng

Mingwei Zhao

Qian Ren

Dongping Zheng

Lifei Wang

Xiaoling Liu

Mei Han

Yanping Song

Jian Ye

Cheng Pei

Jinglin Yi

Xian Wang

Hui Peng

Hong Zhang

Zhanyu Zhou

Xiaoling Liang

Fangliang Yu

Miaoqin Wu

Chaopeng Li

Chunling Lei

Jilong Hao

Luosheng Tang

Huiping Yuan

Shanjun Cai

Qiuming Li

Jingxiang Zhong

Suyan Li

Lin Liu

Min Ke

Jing Wang

Hui Wang

Mengli Zhu

Zenghua Wang

Yang Yan

Feng Wang

Youxin Chen

机构：

[1] Peking Union Medical College Hospital,Ophthalmology Department

[2] Henan Provincial Eye Hospital,Ophthalmology Department

[3] Jinan Second People’s Hospital,Ophthalmology Department

[4] Wuxi Second People’s Hospital,Ophthalmology Department

[5] Guangxi Zhuang Autonomous Region People’s Hospital,Ophthalmology Department

[6] Peking University People’s Hospital,Ophthalmology Department

[7] Shijiazhuang People’s Hospital,Ophthalmology Department

[8] Shanxi Ophthalmic Hospital,Ophthalmology Department

[9] Hebei Eye Hospital,Ophthalmology Department

[10] Eye Hospital,Ophthalmology Department

[11] WMU Zhejiang Eye Hospital,Ophthalmology Department

[12] Tianjin Eye Hospital,Ophthalmology Department

[13] General Hospital of Central Theater Command,Ophthalmology Department

[14] Army Medical Center of PLA,Ophthalmology Department

[15] The First Affiliated Hospital of Xi’an Jiaotong University,Ophthalmology Department

[16] Affiliated Eye Hospital of Nanchang University,Ophthalmology Department

[17] The Affiliated Hospital of Guizhou Medical University,Ophthalmology Department

[18] The First Affiliated Hospital of Chongqing Medical University,Ophthalmology Department

[19] The First Affiliated Hospital of Harbin Medical University,Ophthalmology Department

[20] Qingdao Municipal Hospital,Ophthalmology Department

[21] Zhongshan Ophthalmic Center,Ophthalmology Department

[22] Sun Yat-Sen University,Ophthalmology Department

[23] The First Hospital of Nanchang,Ophthalmology Department

[24] Zhejiang Provincial People’s Hospital,Ophthalmology Department

[25] Huai’an First People’s Hospital,Ophthalmology Department

[26] Xi’an People’s Hospital,Ophthalmology Department

[27] First Hospital of Jilin University,Ophthalmology Department

[28] The Second Xiangya Hospital of Center South University,Ophthalmology Department

[29] The Second Affiliated Hospital of Harbin Medical University,Ophthalmology Department

[30] Affiliated Hospital of Zunyi Medical University,Ophthalmology Department

[31] The First Affiliated Hospital of Zhengzhou University,Ophthalmology Department

[32] The First Affiliated Hospital of Jinan University,Ophthalmology Department

[33] Xuzhou First People’s Hospital,Ophthalmology Department

[34] Renji Hospital Affiliated to Shanghai Jiaotong University,Clinical Research Center

[35] Wuhan University Zhongnan Hospital,Ophthalmology Department

[36] Qilu Pharmaceutical Co.,undefined

[37] Ltd.,undefined

[38] The Second Affiliated Hospital of Xi’an Jiaotong University,undefined

来源：

Ophthalmology and Therapy | 2024年 / 13卷

关键词：

Neovascular age-related macular degeneration; QL1207; Aflibercept; Biosimilar;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：353 / 366

页数：13

共 50 条

[41] Indocyanine green angiography findings in patients with neovascular age-related macular degeneration refractory to ranibizumab switched to aflibercept
Calvo-Gonzalez, Cristina
Reche-Frutos, Juan
Ignacio Fernandez-Vigo, Jose
Donate-Lopez, Juan
Serrano-Garcia, Irene
Fernandez-Perez, Cristina
INTERNATIONAL OPHTHALMOLOGY, 2019, 39 (11) : 2441 - 2448
[42] Indocyanine green angiography findings in patients with neovascular age-related macular degeneration refractory to ranibizumab switched to aflibercept
Cristina Calvo-Gonzalez
Juan Reche-Frutos
José Ignacio Fernández-Vigo
Juan Donate-López
Irene Serrano-García
Cristina Fernández-Pérez
International Ophthalmology, 2019, 39 : 2441 - 2448
[43] Fixed bimonthly aflibercept in naive and switched neovascular age-related macular degeneration patients: one year outcomes
Warwick, Alasdair N.
Leaver, Hannah H.
Lotery, Andrew J.
Goverdhan, Srini V.
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2016, 9 (08) : 1156 - 1162
[44] Aflibercept vs. Ranibizumab: cost-effectiveness of treatment for wet age-related macular degeneration in Sweden
Panchmatia, Hemangi R.
Clements, Karen M.
Hulbert, Erin
Eriksson, Marianne
Wittrup-Jensen, Kim
Nilsson, Jonas
Weinstein, Milton C.
ACTA OPHTHALMOLOGICA, 2016, 94 (05) : 441 - 448
[45] A modified treat-and-extend regimen of aflibercept for treatment-naïve patients with neovascular age-related macular degeneration
Masayuki Ohnaka
Yoshimi Nagai
Kenichiro Sho
Katsuaki Miki
Motoki Kimura
Tomoyuki Chihara
Kanji Takahashi
Graefe's Archive for Clinical and Experimental Ophthalmology, 2017, 255 : 657 - 664
[46] RESPONSE OF PIGMENT EPITHELIAL DETACHMENTS TO INTRAVITREAL AFLIBERCEPT AMONG PATIENTS WITH TREATMENT-RESISTANT NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Broadhead, Geoffrey K.
Hong, Thomas
Zhu, Meidong
Li, Haitao
Schlub, Timothy E.
Wijeyakumar, Wijeyanthy
Chang, Andrew A.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (05): : 975 - 981
[47] A modified treat-and-extend regimen of aflibercept for treatment-na⟨ve patients with neovascular age-related macular degeneration
Ohnaka, Masayuki
Nagai, Yoshimi
Sho, Kenichiro
Miki, Katsuaki
Kimura, Motoki
Chihara, Tomoyuki
Takahashi, Kanji
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 255 (04) : 657 - 664
[48] Efficacy, Durability and Safety of Faricimab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Oedema: Lessons Learned from Registration Trials
Larsen, Helene O.
Grauslund, Jakob
Vergmann, Anna S.
OPHTHALMOLOGY AND THERAPY, 2023, 12 (05) : 2253 - 2264
[49] Assessment of choriocapillaris/Sattler and Haller layer changes after intravitreal injection in eyes with neovascular age-related macular degeneration: aflibercept vs ranibizumab
Altunel, Orhan
Ozsaygili, Cemal
JAPANESE JOURNAL OF OPHTHALMOLOGY, 2022, 66 (02) : 159 - 166
[50] Efficacy and safety of Brolucizumab for neovascular age-related macular degeneration: a systematic review and meta-analysis
Dou, Ran
Jiang, Jian
PEERJ, 2024, 12 : 1 - 16

← 1 2 3 4 5 →